Hancock Whitney Corp Emergent Bio Solutions Inc. Transaction History

Hancock Whitney Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$27.42 - $43.63 $14,669 - $23,342	-535 Reduced 1.67%	31,494 $977,000
Q1 2022 May 12, 2022	BUY	$36.48 - $52.22 $827,621 - $1.18 Million	22,687 Added 242.85%	32,029 $1.32 Million
Q4 2021 Jan 25, 2022	SELL	$33.11 - $55.01 $28,408 - $47,198	-858 Reduced 8.41%	9,342 $407,000
Q3 2021 Nov 04, 2021	SELL	$50.07 - $66.05 $663,527 - $875,294	-13,252 Reduced 56.51%	10,200 $511,000
Q2 2021 Aug 09, 2021	SELL	$56.61 - $80.46 $459,503 - $653,093	-8,117 Reduced 25.71%	23,452 $1.48 Million
Q1 2021 May 14, 2021	BUY	$86.23 - $125.19 $870,319 - $1.26 Million	10,093 Added 47.0%	31,569 $2.93 Million
Q4 2020 Feb 09, 2021	BUY	$79.17 - $111.47 $724,801 - $1.02 Million	9,155 Added 74.3%	21,476 $1.92 Million
Q3 2020 Nov 05, 2020	SELL	$81.91 - $134.94 $1,965 - $3,238	-24 Reduced 0.19%	12,321 $1.27 Million
Q2 2020 Jul 30, 2020	BUY	$54.33 - $89.52 $670,703 - $1.11 Million	12,345 New	12,345 $976,000

160

33.8M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $515M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Hancock Whitney Corp, based on Form 13F filings with the SEC.

Stay updated on Hancock Whitney Corp with notifications on news.